Forte Biosciences (FBRX) IV bid into data

Forte Biosciences (NASDAQ: FBRX) August call option implied volatility is at 230, September is at 275; compared to its 52-week range of 87 to 265 into the expected release of FB-401 Phase 2 data in Atopic Dermatitis.

You May Also Be Interested In

• Robinhood (HOOD) calls more active than puts into quarter results
• Qualcomm (QCOM) call put ratio 1.8 calls to 1 put with a focus on July 31 weekly 170 calls into quarter results
• Barclays Downgrades Forte Biosciences Inc. (FBRX) to Equalweight